Prognostic value of NT-ProBNP/BNP ratio in patients with heart failure and reduced ejection fraction using sacubitril-valsartan: systematic review and post hoc analysis of PARADIGM-HF Trial

被引：0
|
作者：
Eduardo Pitthan, E. [1 ]
Hirakata, V. N. [1 ]
Barbisan, J. N. [1 ]
Rodrigues, C. G. [1 ]
机构：
[1] Inst Cardiol Rio Grande Do Sul, Porto Alegre, RS, Brazil
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1011
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [41] Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction PARADIGM-HF
    Selvaraj, Senthil
    Claggett, Brian
    Pozzi, Andrea
    McMurray, John J. V.
    Jhund, Pardeep S.
    Packer, Milton
    Desai, Akshay S.
    Lewis, Eldrin F.
    Vaduganathan, Muthiah
    Lefkowitz, Martin P.
    Rouleau, Jean L.
    Shi, Victor C.
    Zile, Michael R.
    Swedberg, Karl
    Solomon, Scott D.
    CIRCULATION, 2019, 140 (17) : 1369 - 1379
  • [42] Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial
    Solomon, Scott D.
    Claggett, Brian
    Desai, Akshay S.
    Packer, Milton
    Zile, Michael
    Swedberg, Karl
    Rouleau, Jean L.
    Shi, Victor C.
    Starling, Randall C.
    Kozan, Omer
    Dukat, Andrej
    Lefkowitz, Martin P.
    McMurray, John J. V.
    CIRCULATION-HEART FAILURE, 2016, 9 (03)
  • [43] Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
    Podzolkov, V., I
    Dragomiretskaya, N. A.
    Tolmacheva, A., V
    Shvedov, I. I.
    Ivannikov, A. A.
    Yu, Akyol, V
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (04) : 310 - 319
  • [44] Use Of Sacubitril-valsartan And Associated Outcomes By Race And Ethnicity In Patients With Heart Failure With Reduced Ejection Fraction: Data From Champ-HF
    Chapman, Brittany
    Hellkamp, Anne
    Thomas, Laine
    Albert, Nancy
    Butler, Javed
    Patterson, J. Herbert
    Hernandez, Adrian
    Williams, Fredonia
    Shen, Xian
    Spertus, John
    Fonarow, Gregg
    Devore, Adam
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S33 - S33
  • [45] Correlates Of Plasma Nt-probnp To Cyclic Gmp Ratio In Heart Failure With Preserved Ejection Fraction: An Analysis Of The Relax Trial
    Chiu, Leonard
    Agrawal, Vineet
    Armstrong, David
    Brittain, Evan
    Collins, Sheila
    Hemnes, Anna
    Hill, Joseph
    Lindenfeld, Joann
    Shah, Sanjiv
    Stevenson, Lynne
    Wang, Thomas
    Gupta, Deepak
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 137 - 137
  • [46] Correlates of Plasma NT-proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial
    Chiu, Leonard
    Agrawal, Vineet
    Armstrong, David
    Brittain, Evan
    Collins, Sheila
    Hemnes, Anna R.
    Hill, Joseph A.
    Lindenfeld, Joann
    Shah, Sanjiv J.
    Stevenson, Lynne W.
    Wang, Thomas J.
    Gupta, Deepak K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (07):
  • [47] Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure Post Hoc Analysis of the PARADIGM-HF and PARAGON-HF Randomized Clinical Trials
    Lu, Henri
    Claggett, Brian L.
    Packer, Milton
    Lam, Carolyn S. P.
    Swedberg, Karl
    Rouleau, Jean
    Zile, Michael R.
    Lefkowitz, Martin
    Desai, Akshay S.
    Jhund, Pardeep
    Mcmurray, John J. V.
    Solomon, Scott D.
    Vaduganathan, Muthiah
    JAMA CARDIOLOGY, 2024, 9 (11) : 1047 - 1052
  • [48] Sacubitril/valsartan in real-life European patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis
    Giovinazzo, S.
    Carmisciano, L.
    Toma, M.
    Sormani, M. P.
    Canepa, M.
    Senni, M.
    Porto, I
    Ameri, P.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1028 - 1028
  • [49] Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis
    Kang, Dong-Won
    Kang, Seung-Ho
    Lee, Kyungmin
    Nam, Kyungae
    Kim, Eui-Soon
    Youn, Jong -Chan
    Park, Sun-Kyeong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 400
  • [50] Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis
    Giovinazzo, Stefano
    Carmisciano, Luca
    Toma, Matteo
    Benenati, Stefano
    Tomasoni, Daniela
    Sormani, Maria Pia
    Porto, Italo
    Canepa, Marco
    Senni, Michele
    Metra, Marco
    Ameri, Pietro
    ESC HEART FAILURE, 2021, 8 (05): : 3547 - 3556
12345